Items where authors include "Ford, A.C."
Article
Ford, A.C. orcid.org/0000-0001-6371-4359, Yuan, Y., Park, J.Y. et al. (2 more authors) (2025) Eradication Therapy to Prevent Gastric Cancer in Helicobacter pylori–Positive Individuals: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies. Gastroenterology, 169 (2). pp. 261-276. ISSN 0016-5085
Barberio, B., Gracie, D.J., Black, C.J. et al. (1 more author) (2025) Network Meta‐Analysis: Efficacy of Biological Therapies and Small Molecules as Maintenance Therapy in Ulcerative Colitis. Alimentary Pharmacology & Therapeutics, 62 (1). pp. 4-21. ISSN 0269-2813
Jaafari, H., Houghton, L.A., West, R.M. orcid.org/0000-0001-7305-3654 et al. (9 more authors) (2025) Dietary Patterns Are Associated With Variations in the Global Prevalence and Severity of Rome IV Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology. ISSN 1542-3565
Cuffe, M.S., Staudacher, H.M., Aziz, I. et al. (6 more authors) (2025) Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10 (6). pp. 520-536. ISSN 2468-1253
Khasawneh, M., Mokhtare, M., Moayyedi, P. et al. (2 more authors) (2025) Efficacy of gut–brain neuromodulators in irritable bowel syndrome: an updated systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 10 (6). pp. 537-549. ISSN 2468-1253
Riggott, C., Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Gracie, D.J. et al. (1 more author) (2025) Cumulative Impact of Clinical Disease Activity, Biochemical Activity and Psychological Health on the Natural History of Inflammatory Bowel Disease During 8 Years of Longitudinal Follow‐Up. Alimentary Pharmacology and Therapeutics, 61 (10). pp. 1635-1648. ISSN 0269-2813
Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2025) The case for reducing the use of diagnostic upper and lower gastrointestinal endoscopy. The Lancet Gastroenterology & Hepatology, 10 (4). pp. 285-287. ISSN 2468-1253
Moreau, L.A. orcid.org/0000-0002-0280-6345, Ford, A.C. orcid.org/0000-0001-6371-4359, Brookes, M.J. et al. (15 more authors) (2025) Management of diarrhoea in patients with stable ulcerative colitis with low FODMAP diet, amitriptyline, ondansetron or loperamide: the MODULATE RCT. Health Technology Assessment. ISSN 1366-5278
Camilleri, M. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2025) Review Article: Surrogate Endpoints to Assess Treatment Efficacy in Disorders of Gut–Brain Interaction of Lower Gastrointestinal Tract. Alimentary Pharmacology and Therapeutics, 61 (6). pp. 950-958. ISSN 0269-2813
Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ow, P.-L., Alderson, S.L. et al. (11 more authors) (2025) Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial. Gut. ISSN 0017-5749
Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2025) An evidence-based update on the diagnosis and management of irritable bowel syndrome. Expert Review of Gastroenterology & Hepatology, 19 (3). pp. 227-242. ISSN 1747-4124
O'Connor, A., Gill, S., Neary, E. et al. (2 more authors) (2025) Impact of HADS Anxiety and Depression Scores on the Efficacy of Dietary Interventions for Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 61 (1). pp. 177-185. ISSN 0269-2813
Whelan, K., Ford, A.C. orcid.org/0000-0001-6371-4359, Burton-Murray, H. et al. (1 more author) (2024) Dietary management of irritable bowel syndrome: considerations, challenges, and solutions. The Lancet Gastroenterology & Hepatology, 9 (12). pp. 1147-1161. ISSN 2468-1253
Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Personalisation of therapy in irritable bowel syndrome: a hypothesis. The Lancet Gastroenterology & Hepatology, 9 (12). pp. 1162-1176. ISSN 2468-1253
Din, S., Segal, J., Blackwell, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as induction therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). p1020-p1029. ISSN 2468-1156
Riggott, C., Ford, A.C. orcid.org/0000-0001-6371-4359 and Gracie, D.J. (2024) Review article: The role of the gut–brain axis in inflammatory bowel disease and its therapeutic implications. Alimentary Pharmacology and Therapeutics, 60 (9). pp. 1200-1214. ISSN 0269-2813
Goodoory, V.C., Riggott, C., Khasawneh, M. et al. (2 more authors) (2024) Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care. Alimentary Pharmacology and Therapeutics. ISSN 0269-2813
Goodoory, V.C., Khasawneh, M., Thakur, E.R. et al. (9 more authors) (2024) Effect of Brain-Gut Behavioral Treatments on Abdominal Pain in Irritable Bowel Syndrome: Systematic Review and Network Meta-Analysis. Gastroenterology, 167 (5). p934-943.e5. ISSN 0016-5085
Wright-Hughes, A. orcid.org/0000-0001-8839-6756, Ford, A.C. orcid.org/0000-0001-6371-4359, Alderson, S.L. orcid.org/0000-0002-5418-0495 et al. (19 more authors) (2024) Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT. Health Technology Assessment, 28 (66). ISSN 1366-5278
Gros, B., Blackwell, J., Segal, J. et al. (3 more authors) (2024) Harms with placebo in trials of biological therapies and small molecules as maintenance therapy in inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 9 (11). pp. 1030-1040. ISSN 2468-1156
Thakur, E.R., Shapiro, J.M., Wellington, J. et al. (5 more authors) (2024) A systematic review of yoga for the treatment of gastrointestinal disorders. Neurogastroenterology & Motility. e14915. ISSN 1350-1925
Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (1 more author) (2024) Assessing Diagnostic Performance of Modifications to the Rome IV Criteria for Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (9). pp. 1942-1943. ISSN 1542-3565
Nardone, O.M., Calabrese, G., Bertin, L. et al. (5 more authors) (2024) Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis. Journal of Crohn's and Colitis. jjae133. ISSN 1197-4982
Porcari, S., Ingrosso, M.R., Maida, M. et al. (6 more authors) (2024) Prevalence of irritable bowel syndrome and functional dyspepsia after acute gastroenteritis: systematic review and meta-analysis. Gut, 73 (9). pp. 1431-1440. ISSN 0017-5749
Khasawneh, M., Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2024) Efficacy of Drugs Acting on Histamine 1 Receptors in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. Gastroenterology, 167 (2). 400-401.e3. ISSN 0016-5085
Black, C.J., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. orcid.org/0000-0001-7305-3654 et al. (4 more authors) (2024) Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population. Clinical Gastroenterology and Hepatology. ISSN 1542-3565
Ford, A.C. orcid.org/0000-0001-6371-4359, Staudacher, H.M. and Talley, N.J. (2024) Postprandial symptoms in disorders of gut-brain interaction and their potential as a treatment target. Gut, 73 (7). pp. 1199-1211. ISSN 0017-5749
Ford, A.C. orcid.org/0000-0001-6371-4359, Vanner, S., Kashyap, P.C. et al. (1 more author) (2024) Chronic Visceral Pain: New Peripheral Mechanistic Insights and Resulting Treatments. Gastroenterology, 166 (6). pp. 976-994. ISSN 0016-5085
Khasawneh, M., Shaikh, F.A., Ng, C.E. et al. (3 more authors) (2024) Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden. Neurogastroenterology & Motility. e14756. ISSN 1350-1925
Barberio, B., Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Gracie, D.J. et al. (1 more author) (2024) Natural history and impact of irritable bowel syndrome‐type symptoms in inflammatory bowel disease during 12 months of longitudinal follow‐up. Neurogastroenterology & Motility, 36 (2). e14713. ISSN 1350-1925
Goodoory, V.C. orcid.org/0000-0001-9483-5604, Tuteja, A.K., Black, C.J. et al. (1 more author) (2024) Systematic Review and Meta-analysis: Efficacy of Mesalamine in Irritable Bowel Syndrome. Clinical Gastroenterology and Hepatology, 22 (2). E5. pp. 243-251. ISSN 1542-3565
Barberio, B., Gracie, D.J., Black, C.J. et al. (1 more author) (2024) Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis. Digestive and Liver Disease, 56 (1). pp. 7-14. ISSN 1590-8658
Khasawneh, M., Craig, O.F., Gracie, D.J. et al. (2 more authors) (2023) A Diagnosis of Irritable Bowel Syndrome Using Rome IV Criteria and Limited Investigations is Durable in Secondary Care. Clinical Gastroenterology and Hepatology, 21 (13). pp. 3397-3404. ISSN 1542-3565
Ford, A.C., Wright-Hughes, A., Alderson, S.L. et al. (65 more authors) (2023) Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): a randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 402 (10414). pp. 1773-1785. ISSN 0140-6736
Goodoory, V.C., Khasawneh, M., Black, C.J. et al. (3 more authors) (2023) Efficacy of Probiotics in Irritable Bowel Syndrome: Systematic Review and Meta-analysis. Gastroenterology, 165 (5). pp. 1206-1218. ISSN 0016-5085
Riggott, C., Fairbrass, K.M., Selinger, C.P. et al. (2 more authors) (2023) Impact of Opioid Use on the Natural History of Inflammatory Bowel Disease: Prospective Longitudinal Follow-up Study. Inflammatory Bowel Diseases. ISSN 1078-0998
Visaggi, P. orcid.org/0000-0002-6985-5301, Barberio, B., Del Corso, G. et al. (4 more authors) (2023) Comparison of drugs for active eosinophilic oesophagitis: systematic review and network meta-analysis. Gut, 72 (11). pp. 2019-2030. ISSN 0017-5749
Riggott, C. orcid.org/0000-0002-6927-9498, Fairbrass, K.M. orcid.org/0000-0002-5569-4762, Black, C.J. orcid.org/0000-0001-5449-3603 et al. (2 more authors) (2023) Novel symptom clusters predict disease impact and healthcare utilisation in inflammatory bowel disease: Prospective longitudinal follow-up study. Alimentary Pharmacology & Therapeutics. ISSN 0269-2813
Gunn, D., Topan, R., Fried, R. et al. (21 more authors) (2023) Ondansetron for irritable bowel syndrome with diarrhoea: randomised controlled trial. Efficacy and Mechanism Evaluation, 10 (9). ISSN 2050-4365
Riggott, C., Mikocka-Walus, A., Gracie, D.J. et al. (1 more author) (2023) Efficacy of psychological therapies in people with inflammatory bowel disease: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 8 (10). pp. 919-931. ISSN 2468-1253
Chuah, K. orcid.org/0000-0001-9811-7546, Black, C.J. orcid.org/0000-0001-5449-3603, Tee, V. orcid.org/0000-0002-6562-2666 et al. (6 more authors) (2023) A prospective comparison of UK and Malaysian patients with irritable bowel syndrome in secondary care. Alimentary Pharmacology and Therapeutics, 58 (2). pp. 168-174. ISSN 0269-2813
Jaafari, H., Houghton, L.A. orcid.org/0000-0002-5351-0229, West, R.M. et al. (13 more authors) (2023) The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: results from the Rome foundation global epidemiology study. Neurogastroenterology & Motility, 35 (6). e14574. ISSN 1365-2982
Goodoory, V.C. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2023) Antibiotics and Probiotics for Irritable Bowel Syndrome. Drugs, 83 (8). pp. 687-699. ISSN 0012-6667
Brenner, D.M., Lacy, B.E., Ford, A.C. orcid.org/0000-0001-6371-4359 et al. (6 more authors) (2023) Linaclotide Reduced Response Time for Irritable Bowel Syndrome With Constipation Symptoms: Analysis of 4 Randomized Controlled Trials. The American Journal of Gastroenterology, 118 (5). pp. 872-879. ISSN 0002-9270
Barberio, B., Visaggi, P., Savarino, E. et al. (3 more authors) (2023) Comparison of acid‐lowering drugs for endoscopy negative reflux disease: Systematic review and network Meta‐Analysis. Neurogastroenterology & Motility, 35 (1). e14469. ISSN 1350-1925
Hawkey, C., Avery, A., Coupland, C.A.C. et al. (25 more authors) (2022) Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial. The Lancet, 400 (10363). pp. 1597-1606. ISSN 0140-6736
Black, C.J., Paine, P.A., Agrawal, A. et al. (10 more authors) (2022) British Society of Gastroenterology guidelines on the management of functional dyspepsia. Gut, 71 (9). pp. 1697-1723. ISSN 0017-5749
Black, C.J. and Ford, A.C. orcid.org/0000-0001-6371-4359 (2020) Faecal incontinence is not rare in irritable bowel syndrome. Frontline Gastroenterology, 11 (6). pp. 494-496. ISSN 2041-4137
Ford, A.C. orcid.org/0000-0001-6371-4359, Yuan, Y., Forman, D. et al. (2 more authors) (2020) Helicobacter pylori eradication for the prevention of gastric neoplasia. Cochrane Database of Systematic Reviews, 7. CD005583. ISSN 1361-6137
Rej, A., Avery, A., Ford, A.C. et al. (8 more authors) (2018) Clinical application of dietary therapies in Irritable Bowel Syndrome. Journal of Gastrointestinal and Liver Diseases, 27 (3). pp. 307-316. ISSN 1841-8724